Skip to main content

Table 1 Clinical and echocardiographic characteristics

From: Global longitudinal strain assessment in contrast-enhanced echocardiography in breast cancer patients: a feasibility study

 

Value

Demographic and clinical characteristics

 Age, y

48.41 ± 9.93

 Sex, female

160 (100%)

 Height, cm

157.40 ± 4.67

 Weight, kg

59.19 ± 8.43

 BSA, m2

1.56 ± 0.12

 BMI, kg/m2

23.91 ± 3.41

 Overweight (%)

63 (39.38%)

 Obesity (%)

13 (8.13%)

 Systolic blood pressure, mmHg

121.77 ± 13.03

 Diastolic blood pressure, mmHg

76.81 ± 9.81

 Never smoking (%)

160 (100%)

 Diabetes mellitus (%)

2 (1.25%)

 Hypertension (%)

25 (15.63%)

Treatment-related characteristics

 Radiotherapy (%)

100 (62.50%)

 Endocrine treatment (%)

46 (28,75%)

 Targeted therapy (%)

67 (41.88%)

 Oral chemotherapy drugs (%)

14 (8.75%)

 Left breast expanders (%)

4 (2.50%)

Echocardiographic characteristics

 LVID, mm

44.36 ± 4.49

 RVD, mm

20.25 ± 2.41

 LAD, mm

30.13 ± 4.72

 RAD, mm

32.80 ± 4.58

 IVS, mm

8.97 ± 1.74

 LVPW, mm

8.15 ± 1.31

 LVMi, g/m2

75.53 (65.93, 89.49)

 MV E, m/s

0.77 ± 0.17

 MV A, m/s

0.77 ± 0.21

 e' Sept, cm/s

8.48 ± 2.63

 e' Lat, cm/s

10.89 ± 2.84

 E/e' ratio

8.35 ± 2.30

  1. Data were expressed as: mean ± SD, the median and interquartile interval (first quartile; third quartile) or as a number (percentage)
  2. LVID Left ventricular internal diameter, RVD Right ventricular diameter, LAD Left atrial diameter, RAD Right atrial diameter, IVS Interventricular septal thickness, LVPW Left ventricular posterior wall thickness, LVMi Left ventricular mass index, MV E Mitral valve peak early diastolic velocity, MV A Peak late diastolic velocity, e' Sept Septal peak early velocity, e' Lat Lateral peak early velocity